Cargando…
Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache
OBJECTIVE: To determine the safety of domperidone in the treatment of nausea associated with dihydroergotamine (DHE) infusion and headache. METHODS: We audited our use of domperidone for the inpatient management of nausea, focusing on known safety concerns, particularly potential cardiac arrhythmias...
Autores principales: | Robbins, Nathaniel M., Ito, Hiroyuki, Scheinman, Melvin M., Goadsby, Peter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206996/ https://www.ncbi.nlm.nih.gov/pubmed/27837002 http://dx.doi.org/10.1212/WNL.0000000000003429 |
Ejemplares similares
-
Aprepitant for the management of nausea with inpatient IV dihydroergotamine
por: Chou, Denise E., et al.
Publicado: (2016) -
Cardiovascular Safety Profile and Clinical Experience With High-Dose Domperidone Therapy for Nausea and Vomiting
por: Ortiz, Arleen, et al.
Publicado: (2015) -
Comprehensive clinical phenotyping of nitroglycerin infusion induced cluster headache attacks
por: Wei, Diana Y, et al.
Publicado: (2021) -
EHMTI-0125. Studying the permeability of the blood-brain barrier during migraine attacks using [11C]-dihydroergotamine
por: Schankin, C, et al.
Publicado: (2014) -
Dihydroergotamine (DHE) – Then and Now: A Narrative Review
por: Silberstein, Stephen D., et al.
Publicado: (2019)